Recombinant Human GAL14 Protein，His

GAL14 is a fusion protein derived from the Galectin family, known for its ability to bind β-galactosides, which play crucial roles in various biological processes, including cell-cell interactions, immune responses, and cancer progression. Research on GAL14 is significant due to its potential applications in therapeutic and diagnostic fields. Galectins, including GAL14, have been implicated in tumor development and metastasis, making them attractive targets for cancer treatment strategies. The study of GAL14 not only aids in understanding the molecular mechanisms underlying galectin function but also provides insights into the design of galectin inhibitors that could disrupt their interactions in pathological conditions. Additionally, GAL14's unique properties as a recombinant protein enable its use as a tool in biotechnological applications, such as biosensors and drug delivery systems. As scientists continue to explore the functional roles of GAL14, the protein's applications in regenerative medicine and targeted therapies are also being investigated, highlighting its significance in advancing health care solutions. Overall, the ongoing research on GAL14 signifies its importance in both fundamental biology and clinical applications, emphasizing the need for further exploration of its properties and mechanisms of action.